How Easy Is It to Get Mounjaro on the NHS Right Now?

Step 1, Check whether you fall inside the current NHS cohort

NICE recommended tirzepatide for NHS use in England in December 2024 (TA1026), but the rollout is deliberately staged. Right now, the NHS has opened access to a first cohort: adults with a BMI of 40 or above who also have four or more of five specific weight-related conditions, high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, and type 2 diabetes. A second cohort, covering BMI 35–39.9 with four or more of those same conditions, became eligible from 23 June 2026. For people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, the BMI thresholds each sit 2.5 kg/m² lower throughout the rollout. You can check roughly where you sit using the NHS BMI thresholds for Mounjaro eligibility we've set out, or run your own numbers with the NHS BMI calculator. One quick check worth doing before anything else: look up your GP practice's involvement in the new GP contract (QOF 2026/27), practices can now prescribe under the scheme, but participation is optional, so your surgery may or may not be taking part.

If you don't land inside one of the cohorts that has already opened, later phases are planned. NHS England expects to widen access roughly in stages through 2027, but dates can shift, and nothing in the schedule is guaranteed. The full breakdown of who can get Mounjaro on the NHS covers each cohort and the conditions that count.

Step 2, Find out whether a commissioned service covers your area

Meeting the clinical criteria is necessary, but it isn't sufficient on its own. Tirzepatide must be prescribed within a commissioned NHS service, and availability varies between Integrated Care Boards across England. Some areas have specialist weight management pathways up and running; others are still developing capacity. Scotland, Wales and Northern Ireland each commission weight management medicines through different frameworks, with their own thresholds and timelines, so geography matters as much as BMI. Every NHS patient on tirzepatide is also expected to take part in structured wraparound support covering diet, activity and behavioural change, as outlined in NHS England's guidance on weight management injections. That wraparound requirement is clinically sound, but it does add to the demand on services that are already stretched. If your GP practice is participating in the new prescribing scheme, that may be the fastest NHS route, ask directly at your next appointment.

Step 3, Understand what happens after referral

If your GP confirms you meet the current cohort criteria and refers you into a commissioned pathway, the wait for an initial appointment can still be significant. Specialist weight management services were already under pressure before tirzepatide was added to their remit. Some ICBs are managing demand through phased referral lists; others are still setting up infrastructure. Waiting several months is common, and in some areas longer waits have been reported. There is no national guaranteed wait-time target for weight management medicines equivalent to those for urgent referrals. Our guide on how to get Mounjaro on the NHS walks through the referral process in detail, including what to expect at each stage. The NICE appraisal of tirzepatide (TA1026) sets out the full recommendation, including the review point at six months, if less than 5% weight loss has been achieved at the highest tolerated dose by that point, continuing treatment is formally reviewed. Understanding that framing helps set realistic expectations about what the NHS pathway involves beyond the initial prescription.

What if the NHS route isn't open to you yet?

Most adults asking this question don't currently meet the NHS cohort criteria, or meet them but face a wait that feels unworkable. That's the honest reality, and it's worth naming plainly. The licensed private route involves a clinical assessment by a GPhC-registered prescriber, who reviews your full health picture before any prescription is issued, the same standard of oversight, without the referral queue. Our page on how to get Mounjaro online walks through each step of that process in plain terms, and if cost is a consideration, our Mounjaro cost context page explains what private pricing typically includes and what to watch for. Private treatment isn't the right fit for everyone, but for people who don't qualify for NHS access yet, it is the legal, clinically supervised alternative. A prescriber, not an eligibility checklist, makes the final call, and that's true whether the route is NHS or private. If you'd like to explore whether a slimming clinic offering Mounjaro could be a suitable option for you, check your eligibility with our prescribers at no cost.